Kamada 的季度收益为每股收益 0.10 美元，比普遍预期的 0.05 美元高出 0.05 美元。 Kamada's Qtrly earnings of $0.10 EPS surpassed the $0.05 consensus estimate by $0.05.
Kamada（纳斯达克股票代码：KMDA）公布的季度每股收益为 0.10 美元，比市场普遍预期的 0.05 美元高出 0.05 美元。 Kamada (NASDAQ:KMDA) reported Qtrly earnings of $0.10 EPS, exceeding the $0.05 consensus estimate by $0.05. 该生物技术公司的净利润率为 4.07%，净资产收益率为 5.93%。 The biotech company had a net margin of 4.07% and a ROE of 5.93%. 去年，它的每股收益为 0.11 美元。 In the previous year, it earned $0.11 EPS. KMDA 股票开盘价为 6.02 美元，市值为 3.4599 亿美元，贝塔值为 1.05。 KMDA stock opened at $6.02, with a market cap of $345.99M and a beta of 1.05. HC Wainwright 和 StockNews.com 的分析师均重申了对该股的“买入”评级。 Analysts at HC Wainwright and StockNews.com have both reaffirmed a "buy" rating on the stock.